James Hassard
Corporate Officer/Principal at CRINETICS PHARMACEUTICALS, INC.
Net worth: 1 M $ as of 2024-04-29
Profile
James Hassard is currently the Chief Commercial Officer at Crinetics Pharmaceuticals, Inc. He previously held the position of Chief Commercial Officer at Arrowhead Pharmaceuticals, Inc. from 2020 to 2021.
Prior to that, he was the Vice President-Marketing at Medivation LLC (California) and the General Manager at Amgen BIO Farmaceutica Ltda.
From 2016 to 2020, he served as the Senior Vice President-Marketing & Market Access at Coherus BioSciences, Inc. Mr. Hassard holds an MBA from Nova Southeastern University, Inc. and an undergraduate degree from the University of Toronto.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-04-14 | 29,259 ( 0.04% ) | 1 M $ | 2024-04-29 |
James Hassard active positions
| Companies | Position | Start |
|---|---|---|
| CRINETICS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2022-02-28 |
Former positions of James Hassard
| Companies | Position | End |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2021-08-22 |
| COHERUS BIOSCIENCES, INC. | Sales & Marketing | 2019-12-31 |
| Amgen BIO Farmaceutica Ltda | Corporate Officer/Principal | - |
| MEDIVATION INC | Sales & Marketing | - |
Training of James Hassard
| Nova Southeastern University, Inc. | Masters Business Admin |
| University of Toronto | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. | Health Technology |
| COHERUS BIOSCIENCES, INC. | Health Technology |
| CRINETICS PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Medivation LLC engages in the development and commercialization of novel therapies to treat serious diseases for which there are limited treatment options. The company was founded by Clarence Patrick Machado and David T. Hung in 2004 and is headquartered in San Francisco, CA. | Health Technology |
| Amgen BIO Farmaceutica Ltda |
- Stock Market
- Insiders
- James Hassard
